Altimmune, Inc. Modification Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. P00008 to Contract HHSO100201600008C Between Altimmune, Inc. and U.S. Department of Health & Human Services
Modification Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. P00007 to Contract HHSO100201600008C Between Altimmune, Inc. and HHS/ASPR/BARDA
Modification Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. P00006 to Contract HHSO100201600008C between U.S. Department of Health & Human Services and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2021
Amendment No. P00005 to Contract HHSO100201600008C Between Altimmune, Inc. and U.S. Department of Health & Human Services
Modification Agreements
Altimmune, Inc.
Biotechnology
2019
Amendment No. 0004 to Contract HHSO100201600008C Between U.S. Department of Health & Human Services and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2018
Amendment No. 0001 to Contract HHSO100201600008C Between ASPR-BARDA and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2017
Early Conversion Agreement between Pharmathene, Inc. and Note Holders (October 2010)
Modification Agreements
Altimmune, Inc.
Biotechnology
DE
2010
Consent, Assumption, and Second Loan Modification Agreement among Silicon Valley Bank, Oxford Finance Corporation, and PharmAthene, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2009
Amendment Agreement to Sale and Purchase Agreement for Avecia Vaccines Business between Avecia Investments Limited, PharmAthene, Inc., and Others (April 2, 2008)
Modification Agreements
Altimmune, Inc.
Biotechnology
2008
Amendment to Unit Purchase Option between Healthcare Acquisition Corp. and Maxim Partners, LLC
Modification Agreements
Altimmune, Inc.
Biotechnology
2007